|
Japan Drugs & Pharmaceutical Industry News is an EIN News Service for health professionals. Constantly updated news and information about Japan Health.
Latest Japan Drugs & Pharmaceutical Industry News
- UPDATE 1-Pfizer says may enter Japan generic drug market 19 Nov 2009 04:10 GMT
... * Japan generic drugmaker shares rise, shrug off news ... rise, shrug off news (Recasts with confirmation) TOKYO, Nov 19 (Reuters) - Pfizer Inc ( ... America, Europe, Australia and New Zealand. The Japanese market for generic drugs is expected to ...
- Pfizer may enter Japan generic drug market 19 Nov 2009 06:19 GMT
... it may start selling generic drugs in Japan from 2011 as part of its efforts ... made by firms such as India's Aurobindo Pharma. “Pfizer is considering entering the generic drug ... America, Europe, Australia and New Zealand. The Japanese market for generic drugs is expected to ...
- GlaxoSmithKline calls for suspension of new-flu vaccinations in Canada [Kyodo News International, Tokyo] 23 Nov 2009 16:14 GMT
... [Kyodo News International, Tokyo] Kyodo News International (Tokyo, Japan) - Nov. 23, 2009 Nov. 23--WASHINGTON -- ... with specific serial numbers, they said. The Japanese health ministry was informed of the development ...
- Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs Syndrome 19 Nov 2009 11:51 GMT
... TOKYO & SANTA CLARA, Calif.--(BUSINESS WIRE)-- Astellas Pharma ... Pharmaceuticals and Medical Device Agency (PMDA) in Japan for ASP8825 (gabapentin enacarbil), also known as ... as a treatment for RLS; U.S. and Japanese regulatory processes and the timing thereof; and ...
- Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 19 Nov 2009 12:12 GMT
... Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless ... Approval of ASP8825/XP13512 for Restless Legs Syndrome TOKYO & SANTA CLARA, Calif. - (BUSINESS WIRE) ... as a treatment for RLS; U.S. and Japanese regulatory processes and the timing thereof; and ...
- Japan not quite the market for our generics 25 Nov 2009 23:10 GMT
... generic drugs is drawing big stakeholders in Japan. Teva, Mylan, Daiichi Sankyo and now Pfizer ... are making every move to ensure the Japanese generic market is exploited at the right ... traversing the entire chain up to the pharmacy level is extremely complex, requiring significant spend ...
- Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval 19 Nov 2009 11:54 GMT
... Pharmaceuticals and Medical Device Agency (PMDA) in Japan for ASP8825 (gabapentin enacarbil), also known as ... About Astellas Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to ... as a treatment for RLS; U.S. and Japanese regulatory processes and the timing thereof; and ...
- Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs Syndrome (BIZ) 19 Nov 2009 11:50 GMT
... to submit the NDA for ASP8825 in Japan," said Masafumi Nogimori, Astellas' president and chief ... on a percentage basis. , located in Tokyo, Japan, is a pharmaceutical company dedicated to ... as a treatment for RLS; U.S. and Japanese regulatory processes and the timing thereof; and ...
- Japan Hot Stocks-JAL, Sharp, property developers, chip-linked 18 Nov 2009 02:34 GMT
... TOKYO, Nov 18 (Reuters) - The benchmark Nikkei ... first time since its 2002 re-listing after Japan's transport minister commented he had never said a ... AS PRESIDENT SAYS TO WIN COMPETITION** Sawai Pharmaceutical edged up 1.7 percent to 4,840 yen, ...
- Japan Hot Stocks-Chip-linked shares, Sawai, Tokyo Tatemono 18 Nov 2009 01:33 GMT
... TOKYO, Nov 18 (Reuters) - The benchmark Nikkei ... AS PRESIDENT SAYS TO WIN COMPETITION** Sawai Pharmaceutical edged up 1.7 percent to 4,840 yen, ... facing anticipated competition against Teva Pharmaceutical in Japan. The broader pharmaceutical sector inched up 0.5 percent. ...
- Japan Hot Stocks-Property developers, chip-linked shares, Sawai 18 Nov 2009 01:53 GMT
... TOKYO, Nov 18 (Reuters) - The benchmark Nikkei ... AS PRESIDENT SAYS TO WIN COMPETITION** Sawai Pharmaceutical edged up 1.7 percent to 4,840 yen, ... facing anticipated competition against Teva Pharmaceutical in Japan. The broader pharmaceutical sector inched up 0.5 percent. ...
- Japan Hot Stocks-Sharp, property developers, chip-linked shares 18 Nov 2009 02:13 GMT
... TOKYO, Nov 18 (Reuters) - The benchmark Nikkei ... AS PRESIDENT SAYS TO WIN COMPETITION** Sawai Pharmaceutical edged up 1.7 percent to 4,840 yen, ... facing anticipated competition against Teva Pharmaceutical in Japan. The broader pharmaceutical sector inched up 0.5 percent. ...
- Japan Hot Stocks-Takefuji, JAL, Sharp, property developers 18 Nov 2009 03:13 GMT
... TOKYO, Nov 18 (Reuters) - The benchmark Nikkei ... first time since its 2002 re-listing after Japan's transport minister commented he had never said a ... AS PRESIDENT SAYS TO WIN COMPETITION** Sawai Pharmaceutical edged up 1.7 percent to 4,840 yen, ...
- Genedata unveils new Japanese web... 23 Nov 2009 16:50 GMT
... related life sciences, today announced its new Japanese web site (www.genedata.jp), which enhances knowledge sharing ... closely follows an expansion of Genedata in Japan and supports the growing customer base in ... College of Medicine, NCC Japan, RIKEN, and Tokyo University. The success in Japan correlates directly ...
- Japan Hot Stocks-Kawasaki Heavy, Ain Pharmaciez, Tokushima Bank 25 Nov 2009 05:54 GMT
... TOKYO, Nov 25 (Reuters) - The benchmark Nikkei ... completion of a pension deficit amortisation. Ain Pharmaciez climbed 3.4 percent to 2,280 yen after ... in debt, the fifth-largest corporate failure in Japan this year. Tokushima, which said it had about ...
Powered by 
Japan Health News Sections
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
| |
Healthcare Industry Today
|